Clinical trial
Clinical Evaluation of i-STAT Analyzer for Glucose, Hematocrit and Sodium
NCT02897154 is registered in ClinicalTrials.gov with Abbott Point of Care as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of i-STAT Analyzer for Glucose, Hematocrit and Sodium
- Lead sponsor
- Abbott Point of Care
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 10, 2016
- Completion date
- March 15, 2017
- Enrollment
- 297 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
analytical performance of sodium, glucose and hematocrit assays by the i-stat 500 (alinity) analyzer